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Introduction: Recent evidence suggests that the consumption of essential amino acids
(AA) and/or those abundantly present in collagen may have the capacity to influence the
synthesis of new collagen in ligaments and tendons, when tissue perfusion is optimized
(e.g., during exercise). However, little is currently known about the bioavailability of
these AAs in blood after the consumption of various collagen and diary protein
sources: such information is needed to develop potentially useful dietary and supplement
intake strategies.
Objectives: The aim of the current study was to characterize blood AA concentrations
in response to consumption of collagen and dairy protein sources; specifically, maximum
concentrations, the timing of maximum concentration, and total (area under the curve)
exposure above baseline.
Methods: A 20g serve of various dairy and collagen proteins, and a 300mL serve
of bone broth were consumed by healthy, recreationally active males after an overnight
fast. Blood samples were drawn every 20min for a total of 180min, for analysis of plasma
AA concentrations. Total AA, essential AA and collagen specific AAs were analyzed for
maximum concentration, timing of peak, and area under the curve.
Results: In general, protein intake was associated with a similar increase in total and
collagen specific AAs, except for collagen proteins being a superior source of glycine
(683 ± 166 µmol/L) compared to 260 ± 65 µmol/L for dairy proteins (P < 0.0001),
whilst dairy proteins were a superior source of leucine (267 ± 77 µmol/L) compared to
189± µmol/L for collagen proteins (P < 0.04). Although there were several differences in
the bioavailability of hydrolysed compared to non-hydrolysed proteins, this only reached
statistical significance within the dairy proteins, but not for collagen proteins.
Conclusions: The intake of collagen proteins result in higher plasma peaks of glycine,
whilst the intake of dairy proteins result in higher plasma peaks of leucine. This information
may support further investigations, and identification of key AAs that may support
exercise in the synthesis of collagen.
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INTRODUCTION
Literature suggests that ligaments and tendons are similar to
muscle in being dynamic structures that respond to mechanical
loading with tissue hypertrophy (1–3). Larger tissues with
more densely packed collagen fibrils have a greater capacity to
withstand force, and thereby exert greater injury protection (4).
On the other hand, smaller tissues with disorganized collagen
fibrils have been associated with higher injury risk, such as
the development of tendinopathies (1). Although the amino
acids (AAs) required for myofibrillar tissue formation have been
well-documented (5–9), evidence regarding the potential role
of collagen precursors (e.g., proline, glycine and lysine) and/or
stimulatory AAs (e.g., leucine) in the synthesis of new collagen
in ligaments and tendons is still emerging. Furthermore, the
requirement for an appropriate exercise stimulus to support
tissue perfusion appears essential (10–13).
Leucine, an essential amino acid (EAA), has been the subject
of extensive research for its role in stimulating myofibrillar
protein synthesis (6). Leucine exerts its effect on the mammalian
target of rapamycin (mTOR), which results in a signaling cascade
leading to the synthesis of myofibrillar protein in muscle tissue
(14). In the context of connective tissue, work undertaken
in an animal model has suggested an increase in collagen
synthesis in the deep digital flexor tendon of malnourished rats
in association with a leucine-rich diet, and further enhanced
when combined with physical stimulation (15). Similarly, in
humans, the ingestion of leucine-rich whey protein, coupled
with resistance training, has been shown to lead to patellar
tendon hypertrophy, with the proximal cross-sectional area
(CSA) increasing by 14.9 ± 3.1%, compared to 8.1 ± 3.2% for
the placebo group (16), but no change in distal or mid tendon
CSA. However, it is highly plausible that this increase occurred
secondary to a distinct increase in the size of the quadriceps
muscle, acting as a stimulatory load on the tendon (17).
In addition to the stimulatory role of leucine on the protein
synthetic machinery, it is likely that other AAs, such as those
found in large quantities in collagen protein (e.g., glycine, proline,
and lysine) play a role in the synthesis of new collagen. Proline
is a conditionally essential amino acid (CEAA), which plays
a role in the formation and structural integrity of collagen
fibrils (18). Indeed, in older individuals, ingestion of leucine
and proline in the form of casein protein, in combination
with resistance training, resulted in a trend toward a higher
fractional synthetic rate of collagen compared to whey protein
(19). In an engineered ligament model, it has been shown that
the addition of 50µM proline with 50µM ascorbic acid, to
a media rich in AAs such as leucine and glycine, increased
ligament collagen content from 1.34 ± 0.2% to 8.34 ± 0.37%
(20). More recently, work from our group has shown that the
consumption of 15 g of dietary collagen; 1 h prior to intermittent
exercise led to an increase in procollagen I N-terminal propeptide
(P1NP), compared to a placebo control (21). Additionally, an
in vitro arm of the same study, displayed an increase in the
collagen content and mechanical properties of an engineered
ligament treated with serum obtained post ingestion of dietary
collagen (21). Thus, it is plausible that a combination of EAA,
to upregulate synthetic machinery, and CEAA to supply AA
building blocks is required during the synthesis of collagen
protein. Although these findings are promising, it remains
unclear as to the value of hyper-aminoacidemia in the synthesis
of new collagen, and whether these amino acids work in isolation
or synergistically.
In line with this, there is emerging evidence of benefits
associated with the ingestion of collagen peptides in a range
of collagen containing tissues, including increased collagen
synthesis (22, 23), improved body composition (24, 25),
reduced pain (26–28) and the slowing of degenerative diseases
such as osteoarthritis (29, 30). It has been suggested that
hydrolysis of collagen protein prior to ingestion allows
two and three amino acid peptides to pass across the
mucosal barrier equating to a higher expression and therefore
biosynthesis within the tissue matrix (31). This was illustrated
in a recent study whereby the consumption of hydrolysed
collagen proteins resulted in a higher bioavailability of AAs
compared to non-hydrolysed collagen protein and a placebo
control (32). Furthermore, it has recently been shown that
the consumption of collagen peptides resulted in a higher
expression of collagen signaling proteins, compared to a placebo
control (24).
Accordingly, we aimed to determine the bioavailability [i.e.,
timing, maximum concentration, and area under the curve
(AUC)] of TAA, EAA, and key AAs proposed to support the
synthesis of new collagen, after the consumption of a selection of
hydrolysed and non-hydrolysed collagenous, and dairy proteins,
and a collagenous food source. This data would be of benefit to
allow further investigations into a range of practical questions:
• The optimal food source/supplement, AA and/or
combinations of AAs that may support exercise in increasing
collagen synthesis.
• The optimal timing to consume this food source/ supplement
and/or AA(s) prior to an exercise bout.
• Whether there is increased bioavailability from the
consumption of hydrolysed vs. non-hydrolysed forms of
collagenous and/or dairy proteins.
MATERIALS AND METHODS
Subjects and Ethics
Fifteen healthy, recreationally active, male subjects (30 ±
5 years; 80 ± 8 kg BM) with no current collagen-related
disease or known protein allergies were recruited for the
study. The current study formed part of a larger study, which
necessitated a male subject population given the influence of
female sex hormones of ligament health (33). Sample size
was chosen using power estimation determined in previous,
similar studies (34, 35). The Human Ethics Committee of the
Australian Institute of Sport granted approval for this study
(20170607) and written informed consent was received from
participants prior to its commencement. The protocol was
registered with the Australian New Zealand Clinical Trials
Registry (ANZCTR12617000923369).
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Protein Source and Preparation
Four collagen and two high leucine dairy protein sources were
selected for the study. These included a hydrolysed and non-
hydrolysed collagen powder: Gelita (Pep) and gelatin (Gel),
respectively; a hydrolysed and non-hydrolysed dairy protein
supplement: calcium caseinate (Cas) and hydrolysed casein
(HCas), respectively; a liquid collagen supplement (LCol) and
one collagenous food source: bone broth (BBr). Further details
of these protein sources can be seen in Table 1. We chose a
standard dose of 20 g for all powdered supplements and 60mL
of liquid collagen (equivalent to 20 g of collagen protein as per
manufacturer information). This dose was slightly higher than
used in previous work (21), due to the benefits associated with
increased amino acid availability (36, 37). The bone broth used
in this study was chosen on the basis of the results of our
previous work (38) in which this preparation was found to have
a higher protein content than other broths assessed, and within
the range provided by the reference supplements in a standard
serve [further details of the broth used in this study; “chef
prepared bone broth” are available elsewhere; (38)]. Furthermore,
we decided on a 300mL serve as a representative portion size that
would be practical to consume within the prescribed time-period,
as we would not ascertain total protein content of this broth
prior to commencing the study. Analysis of the batch actually
consumed in this study, subsequent to the trials, found that it was
considerably higher than expected. Nevertheless, by purchasing a
bulk volume of the broth (5 L), and mixing it well before dividing
it into 300mL serves, we achieved consistency between the serves
consumed by subjects.
To maintain consistency across all experimental protocols, all
protein sources were served warm, and in/with the same amount
of fluid (300mL) achieved via the addition of water. Supplements
were provided in a counter-balanced, randomized fashion, with
at least 48 h between trials. All protein sources were assessed for
full amino acid profiles analyzed using Ultra Performance Liquid
Chromatography (Waters AccQTag Ultra) (Australian Proteome
Analysis Factory, Macquarie University, Sydney, NSW).
Experimental Protocol and Analysis
Participants fasted overnight (>10 h) prior to attending the
laboratory at the Australian Institute of Sport between 5:30
and 7 a.m. On waking, participants were allowed to consume
250mL of water to ensure adequate hydration for the
blood collections but instructed to arrive to the lab in a
rested state to avoid significant elevations to heart rate that
would increase blood flow. On arrival, a 22G indwelling
cannula was inserted into the antecubital vein for blood
collection by a trained phlebotomist, and a baseline (BL)
blood sample was collected. Immediately after, the protein
source was prepared and given to participants who were
instructed to consume it within 5min, sipping slowly throughout.
Completion of the 5min period was considered as t = 0.
To standardize gastric emptying, no other fluid was available
for 60min following consumption, and then ad libitum water
consumption was permitted. Immediately after the consumption
of the protein source, participants were asked to fill out
a feedback form (as outlined below). Blood samples were
then collected every 20min for 180min into 2mL lithium
heparin Vacuette tubes (Greiner Bio-One, Kremsmünster,
Austria). Immediately after each blood collection, samples
were centrifuged at 1,500 ×g for 10min at 4◦C. The
resulting plasma was separated and stored at −80◦C until
further analysis. Once the 180min period was concluded the
cannula was removed and participants were allowed to leave
the laboratory.
Once all plasma samples were collected, they were transported
to Maastricht University for analysis of full amino acid
profiles using liquid chromatograph mass spectrometry (UPLC-
MS; ACQUITY UPLC H-Class with QDa; Waters, Saint-
Quentin, France). Briefly, samples were prepared according to
manufacturer’s instructions, with an internal standard added.
Fifty microliters of blood plasma was deproteinised using
100 µL of 10% sulfosalicyclic acid (SSA) with 50µM of
metabolomics amino acid mix standard (MSK A2) (Cambridge
Isotope Laboratories, Massachusetts, USA). Subsequently, 50
µL of ultra-pure demineralized water was added and samples
were centrifuged. After centrifugation, 10 µL of supernatant
was added to 70 µL of Borate reaction buffer (Waters, Saint-
Quentin, France). Twenty µL of AccQ-Tag derivatising reagent
solution (Waters, Saint-Quentin, France) was then added, and
the solution was heated to 55◦C for 10min. Of this 100 µL
derivative, 1 µL was injected and measured using UPLC-MS.
Due to the interests of this study, we have reported
concentrations of TAA, EAA, and a selection of AAs which
have been suggested to be involved in the synthesis of collagen
(including proline, glycine, lysine and leucine) (16, 19, 21, 39).
Protein Source Acceptability
The feedback form completed by subjects immediately after
consuming a test product provided four questions in the format
of a Likert scale (40), and one question with a yes or no response.
The questions are outlined in Table 3 and included questions
related to acceptability and palatability. While we acknowledge
that this is not a validated questionnaire, it was intended that
this feedback would provide practical insight into the use of this
product for connective tissue health purposes.
Statistics
Trapezoidal rule (41) adjusted to baseline concentration was
applied to calculate the area under curve (AUC) of the amino
acid concentration. Statistical analysis were performed using
GraphPad Prism version 7.00 for Windows (GraphPad Software,
La Jolla California, USA). Data were checked for normality
using a D’Agostino & Pearsons normality test. A repeated-
measures One-way ANOVA by General Linear Models (GLM)
was used to compare the effects of different supplements on
outcome variables (plasma amino acid content for: baseline; BL,
observed maximum concentration; Cmax Obs, timing of peak;
Tmax and AUC). Tukey’s method was used to adjust for multiple
comparisons between different groups.
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TABLE 1 | Details of collagen and non-collagen (dairy) protein sources, and collagen specific amino acid profiles per serve of select food/supplement.














Details Calcium caseinate Hydrolysed casein
powder




Chef made bone broth
Abbreviation Cas HCas Gel Pep LCol BBr
Serve 20 g 20 g 20g 20g 60mL 300 mL
Cost per serve $ 0.70 $ 1.24 $ 0.74 $ 3.00 $ 5.37 $ 4.50
Manufacturer stated total
protein per serve (g)
20 20 20 20 20 N/A
TAA per serve (mg)* 19,172 19,378 20,108 20,594 17,892 52,260
EAA per serve (mg)* 8,306 8,368 4,944 5,858 4,392 13,320
Proline per serve (mg)* 2,038 2,060 2664 2,722 2,406 6,420
Glycine per serve (mg)* 360 354 4,750 4,904 4,212 11,760
Lysine per serve (mg)* 1,422 1,468 696 746 630 1,740
Leucine per serve (mg)* 1,782 1,786 588 584 516 1,710
EAA, Essential Amino Acids; TAA, Total Amino Acids.
*Calculation based on free amino acid molecular weight.
Cysteine and typtophan have not been included in analysis, which account for < 5% in total.
RESULTS
Total Protein and Amino Acid Content of
Selected Collagen and Dairy Proteins
The composition per serve of the protein sources (total protein,
TAA, EAA and selected AAs) is displayed in Table 1. Full
amino acid profiles are available as Supplementary Table 1. The
supplements (Cas, HCas, Gel, Pep, and LCol) provided 19.3 ±
0.8 g protein per 20 gram serve, whereas BBr provided 52.2 g
of protein per 300mL serve. Per serve, BBr contained the
highest levels of all selected AAs, with the exception of leucine,
which was provided in the highest amount in the dairy protein
supplements, HCas and Cas at ∼1,540mg per serve. AA profiles
of proline, glycine, lysine and leucine of protein sources of similar
derivatives (e.g., dairy and collagen proteins), were comparable
in their amino acid content. Liquid collagen provided the lowest
levels of all AA among the collagen protein sources in this study.
Observed Maximum Concentration (Cmax Obs)
Figure 1 displays the time course of the appearance of TAA,
EAA, and the selected AAs in the plasma over 180min.
Kinetic parameters of TAA, EAA, and selected AAs after the
consumption of collagen and dairy protein sources are displayed
in Table 2, as means and SD. There were no differences in
BL levels for TAA, EAA or any of the AAs between protein
sources (P > 0.2).
In terms of TAA, Cmax Obs was similar for all protein sources,
except for Cas which was significantly lower (P < 0.04) than
all protein sources and LCol which was significantly lower than
Pep (P = 0.03). HCas was significantly higher for Cmax Obs
for EAA than all other protein sources (P < 0.0001) while Cas
was only higher than BBr and LCol (P < 0.04). There was no
difference in Cmax Obs of EAA for any of the collagen protein
sources (P > 0.1). The Cmax Obs of proline was similar (P > 0.1)
for all protein sources other than Cas, which was significantly
lower than the others (P < 0.001). HCas provided the highest
Cmax Obs for lysine compared to all other protein sources (P
< 0.002). Collagen proteins provided a higher Cmax Obs for
glycine compared to Cas and HCas (P < 0.0001) while there
was no difference between the dairy protein sources (P = 0.8).
Meanwhile, HCas provided the highest Cmax Obs of leucine
compared to all collagen proteins (P = 0.0001) and Cas also had
a higher Cmax Obs for leucine than these products (P < 0.04).
However, differences in Cmax Obs for leucine between any of the
collagen proteins failed to reach significance (P > 0.06).
Timing of Maximum Concentration (Tmax)
Results of Tmax in Table 2 illustrate a similar time course for TAA
for all products except an earlier peak with HCas than BBr and
Gel (P < 0.02). There was no difference in Tmax of EAA with
all protein sources peaking between ∼ 30 and 50min (P > 0.1).
Tmax of proline for BBr was slower than all other protein sources
(P < 0.002). Although the time to peak for proline was slower
for the non-hydrolysed proteins compared to the hydrolysed
proteins, this did not reach statistical significance (P > 0.05).
BBr was the slowest to peak for glycine, and was significantly
slower than Pep and LCol (P < 0.001). The Tmax of glycine for
Gel was also found to be slower than for Pep (P = 0.04). There
was no difference in Tmax for leucine between any of the protein
sources, with all peaking between∼ 30 to 50min (P > 0.04). The
only difference for lysine Tmax was a quicker peak with BBr than
HCas (P = 0.001).
Area Under the Curve (AUC)
Figure 2 displays the AUC of amino acid concentrations in
plasma after consumption of the protein sources. BBr provided
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FIGURE 1 | Time course of plasma amino acid concentrations over 180 min after the consumption of collagen or dairy protein sources. Data presented as
mean ± SD.
the highest AUC for TAA at 91,029 ± 29,630 µmol/L/180min,
which was significantly higher than both dairy proteins [Cas and
HCas at 27,265 ± 14,130 µmol/L/180min and 36,042 ± 12,833
µmol/L/180min, respectively (P < 0.0001)] but not significantly
different to any of the collagen protein supplements [7,7052 ±
2,4304, 84,664 ± 20,582 and 71,882 ± 19,085 µmol/L/180min
for Gel, Pep and LCol, respectively (P > 0.2)]. However,
as seen in Figure 1, plasma AAs after consumption of BBr
remained elevated at the completion of 180min, particularly
for proline and glycine. Cas provided the lowest AUC for
TAA, and was significantly lower than all collagen supplements
(P < 0.0002), but not HCas (P = 0.6). Although hydrolysed
supplements appeared to have a higher AUC for TAA than
their non-hydrolysed counterparts, this was not statistically
different for either collagen or dairy proteins (P > 0.6).
Collagen proteins had a higher AUC than dairy proteins for
TAA (81,157 ± 8,419 and 31,654 ± 6,206 µmol/L/180min,
respectively, P < 0.0001).
HCas provided the highest AUC for EAA at 55,992 ± 15,675
µmol/L/180min, which was significantly greater than all other
protein sources (P < 0.003), except Cas which provided an
AUC for EAA of 39,587 ± 18,573 µmol/L (P = 0.2). The
AUC for EAA of Cas, was only significantly higher than LCol
and Pep which provided 8,806 ± 16,410 and 12,238 ± 13,682
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TABLE 2 | Kinetic parameters of total, essential, and collagen specific, amino acid concentration in plasma after the consumption of collagen and dairy protein sources.
Cas HCas Gel Pep LCol BBr Significance
TAA Baseline
(µmol/L)
2± 156 , 234 2±233 , 403 2± 155 , 308 2±178 , 331 2,151 ± 325 2,254 ± 392 P = 0.6430
Cmax Obs
(µmol/L)
3,012 ± 407 3,725 ± 641 3,525 ± 631 3,710 ± 670 3,445 ± 641 3,552 ± 561 P = 0.0004
Tmax (min)
(min/max)
45 ± 35 35 ± 9 59 ± 28 48 ± 27 47 ± 39 64 ± 24 P = 0.0877
EAA Baseline
(µmol/L)
998 ± 116 1,044 ± 170 1,030 ± 135 1,017 ± 148 1,000 ± 147 1,074 ± 142 P = 0.4621
Cmax Obs
(µmol/L)
1,457 ± 137 1,946 ± 292 1,311 ± 211 1,313 ± 190 1,270 ± 198 1,347 ± 138 P < 0.0001
Tmax min
(min/max)
47 ± 36 33 ± 10 47 ± 24 35 ± 31 36 ± 42 51 ± 24 P = 0.3310
Proline Baseline
(µmol/L)
168 ± 47 177 ± 49 163 ± 55 173 ± 62 166 ± 49 170 ± 72 P = 0.7901
Cmax Obs
(µmol/L)
282 ± 68 392 ± 71 381 ± 76 431 ± 113 388 ± 89 386 ± 85 P < 0.0001
Tmax min
(min/max)
56 ± 34 41 ± 9 61 ± 22 55 ± 27 52 ± 38 103 ± 29 P < 0.0001
Glycine Baseline
(µmol/L)
229 ± 67 235 ± 64 226 ± 172 215 ± 176 222 ± 143 229 ± 170 P = 0.5773
Cmax Obs
(µmol/L)
267 ± 67 253 ± 64 674 ± 172 747 ± 176 646 ± 143 666 ± 170 P < 0.0001
Tmax min
(min/max)
67 ± 49 39 ± 49 71 ± 25 48 ± 20 53 ± 26 88 ± 24 P = 0.0103
Lysine Baseline
(µmol/L)
174 ± 33 178 ± 31 179 ± 28 178 ± 58 176 ± 33 183 ± 30 P = 0.8818
Cmax Obs
(µmol/L)
273 ± 31 369 ± 65 269 ± 52 271 ± 50 262 ± 48 272 ± 41 P < 0.0001
Tmax min
(min/max)
51 ± 36 29 ± 10 45 ± 19 41 ± 18 44 ± 33 51 ± 17 P = 0.1629
Leucine Baseline
(µmol/L)
136 ± 17 144 ± 27 145 ± 26 144 ± 28 140 ± 29 158 ± 29 P = 0.1640
Cmax Obs
(µmol/L)
230 ± 31 351 ± 59 184 ± 29 190 ± 34 181 ± 30 203 ± 28 P < 0.0001
Tmax min
(min/max)
47 ± 36 29 ± 10 36 ± 23 29 ± 31 33 ± 41 33 ± 12 P = 0.3768
Data presented as mean ± SD.
µmol/L/180min, respectively (P < 0.006). The lowest AUC of
EAA was provided by LCol at 8,806 ± 16,410 µmol/L/180min,
but this was not different to the other collagen protein
sources (P > 0.8).
In terms of individual AA, the AUC of lysine was greater
for HCas than Gel, Pep and LCol [AUC of 11,187 ± 2,764
µmol/L/180min compared to 7,003 ± 4,340, 6,310 ± 2,714,
and 5,729 ± 3,290 µmol/L/180min, respectively (P < 0.008)].
For leucine, dairy proteins had a higher AUC than all collagen
proteins at 10,187 ± 3,023 µmol/L/180min and 746 ±1,043
µmol/L/ 180min, respectively (P < 0.001). Meanwhile, HCas
provided a higher AUC for leucine than Cas (P = 0.003).
Collagen proteins has a higher AUC than dairy proteins for
proline (25,102 ± 2,345 and 13,547 ± 3,450 µmol/L/180min,
for Gel, Pep, and LCol, respectively P < 0.01), and glycine
[(48,563 ± 4,429 and −1,863 ± 2,255 µmol/L/ 180min
(P < 0.0001)].
Collagen and Dairy Protein Acceptability and
Palatability
Responses to the questions around acceptability and palatability
for each protein source are displayed in Table 3. LCol had the
highest scores individually, and on average, while HCas was rated
the lowest. Despite these differences between products, only 53%
of participants reported being willing to pay the specified price
for either product. Meanwhile, the non-hydrolysed supplements
(which were also the lowest in cost; Table 1), scored 93%
for willingness to pay, if it was found to be beneficial to
connective tissues.
DISCUSSION
A number of AAs have been suggested to play a complementary
role in the synthesis of collagen in ligaments and tendons,
when combined with an appropriate mechanical stimulus (39).
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FIGURE 2 | Area under the concentration—time curve (AUC) of plasma amino acids over 180min after the consumption of dairy and collagen protein sources. Middle
line shows mean, boxes represent 25–75th percentile and whiskers represent min and max values.
There is emerging evidence that the ingestion of key AAs
(including proline, glycine, lysine, and leucine), or combinations
thereof, provide enhanced availability to support the synthesis
of collagen when combined with an appropriate exercise
protocol (42). Accordingly, the aim of the present study was
to characterize the bioavailability (e.g., timing of appearance,
maximum concentration, and AUC) of TAA, EAA, and key
AAs that may be involved in the synthesis of collagen,
after the ingestion of a selection of collagen and dairy
protein sources.
In general, plasma AA responses reflected the AA profiles of
the consumed supplement, except in the case of the casein, and
bone broth. These both resulted in a lower and more prolonged
appearance of AAs in the blood over the 180min following
consumption (See Tables 1, 2 and Figure 2). This is likely due
to various components known to slow gastric emptying such as
the fat content of the BBr (43), and the clotting of casein in the
stomach after ingestion (44). However, it is also plausible that the
delayed gastric emptying of BBrmay be related to the volume was
consumed. As can be seen in Figure 1, the plasma concentration
of AAs after consumption of BBr remained elevated at the
180min mark, and most likely would have continued to be
available at a higher amounts in the blood beyond the 3 h that
were monitored for this study.
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TABLE 3 | Likert scale of protein source feedback and palatability.
Question
(1–7)
Cas HCas Gel Pep LCol BBr Significance
Serve size 20 g 20 g 20g 20g 60mL 300mL P < 0.001
1 4 (1–7) 3 (1–5) 4 (1–7) 5 (2–7) 6 (307) 5 (2–7) P < 0.001
2 6 (3–7) 5 (2–6) 6 (2–7) 6 (2–7) 7 (4–7) 6 (2–7) P = 0.032
3 6 (2–7) 5 (1–7) 6 (2–7) 6 (2–7) 7 (5–7) 6 (2–7) P = 0.044
4 6 (3–7) 4 (1–7) 6 (1–7) 6 (2–70) 7 (4–7) 6 (2–7) P = 0.006
5 (% Yes) 93 53 93 60 53 73 -
*Question 1: The palatability (taste, texture) of the product was acceptable.
*Question 2: The volume of the product (300mL) was acceptable to consume in the time specified (5min).
*Question 3: The volume of the product would be acceptable to consume within 20–40min prior to exercise.
*Question 4: I would be willing to consume this product at least twice a day as part of a rehabilitation program.
**Question 5: Would you be willing to pay the specified amount for one serve of the product if it was beneficial to connective tissue health?
Data presented as median (range).
1, strongly agree; 7, strongly disagree.
*Out of 1 (strongly agree) to 7 (strongly disagree).
** % out of 100.
It has been proposed that AAs play a supportive, rather than
stimulatory role in the synthesis of collagen within ligaments
and tendons (21, 39, 45). Meanwhile, exercise has been shown
to be a potent regulator of collagen turnover resulting in an
upregulation of collagen synthesis for a period of up to 72 h
(46). Exercise results in an increase in hormones that have been
shown to stimulate the synthesis of collagen in connective tissue
(e.g., growth hormone, and insulin-like growth factor 1) (47).
As ligaments and tendons are poorly vascularised tissues, it
may be sensible to isolate the provision of AAs to scenarios
involving the exercise-induced enhancement of blood flow (48).
Therefore, protein sources that achieve higher AA peaks over a
shorter period of time (e.g., HCas) may be considered optimal,
whereas a slower release of key AAs over an extended period
of time (e.g., with BBr) may not be as easily matched to
enhanced tissue blood flow. Literature to date suggests that
there is dose related response to the key AA involved in
the synthesis of collagen. Indeed, Shaw et al. (21) illustrated
that a 15 g dose of gelatin resulted in an increased availability
of AAs and collagen synthesis than a 5 g dose, resulting in
improvements to tissue mechanics in engineered ligaments in
vitro. Peak blood concentrations of glycine and proline in the
current study (∼650–750 and 350–450 µmol/L, respectively)
were slightly higher than those reported in previous work [i.e.,
448 ± 165 and 238 ± 77 µmol/L in Shaw et al. (21)]. This is
to be expected given the slightly higher dose within our current
protocol. However, others have shown similar plasma values
after the ingestion of 35 g of collagenous protein (32) which
they suggest shows an upper threshold to the AA availability
of collagen proteins. In general since all AAs appeared to peak
between 30 and 60min (Table 2), the consumption of ∼ 20 g of
protein within the 30–60min prior to exercise would ensure the
optimal availability of AAs at a time when synthetic machinery
is upregulated, and tissue perfusion supported (13, 46, 49). It
should be noted, however, that whether the increased availability
of AAs within the plasma results in an increased availability of
AAs around the target tissue (e.g., the peritendinous fluid), where
it is able to be utilized and integrated into the tissue is yet to
be determined.
While the maximum concentrations of total AA present
within the plasma after the ingestion of collagen and high leucine
dairy proteins were comparable, dairy proteins provided a larger
Cmax Obs and AUC of leucine, while hydrolysed casein provided
a higher Cmax Obs of EAA than both dairy and collagen proteins,
and collagen proteins were superior in terms of glycine. Such
differentiation mean that no protein source was superior in terms
of all AAs that are potentially implicated in collagen synthesis.
If subsequent research identifies the benefits of EAA as well
as collagen precursors (e.g., proline and glycine), a case could
be made for the consistent intake of EAA (i.e., the current
guidelines for regular intake of high-quality protein sources over
the day), with a supplemental and/or food source of collagenous
protein consumed at key periods i.e., prior to exercise. The
lack of such a pattern may also detract from the health of
connective tissues.
It has been proposed that hydrolysed proteins are superior to
non-hydrolysed forms in providing a higher AA bioavailability;
more specifically, being able to reach a target tissue more quickly
and with a higher peak concentration (31, 32, 50). Within the
present study, the plasma characteristics of hydrolysed and non-
hydrolysed dairy proteins showed some differences, but these
were not seen with the collagen proteins. Our findings are
similar to the study of Koopman and co-workers where ingestion
of 35 g of hydrolysed casein protein resulted in an increased
bioavailability and incorporation rate of AAs into skeletal muscle
protein than intact casein (50). However, while another more
recent study showed that the ingestion of 35 g of enzymatically
hydrolysed collagen resulted in a higher bioavailability of several
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AAs compared to non-enzymatically hydrolysed collagen (32),
we did not find any difference in the bioavailability of gelatin
compared to a hydrolysed peptide powder. It is possible that
differences in processing methods accounted for this finding
as it has been suggested to influence digestibility and therefore
bioavailability of AAs (51).
In terms of the limitations of this study, we acknowledge
that the questionnaire relating to acceptance and palatability
of the protein sources used in this study was not a validated
tool. Nevertheless, it provided insight into factors that are
likely to affect the compliance of the use of protein sources
that have potential benefit for collagenous tissues. Indeed, it
indicated that despite the superiority of HCas over Cas in
terms of AA availability, its poor scores for taste/texture are
likely to affect consumer uptake and compliance with regular
use. On the other hand, non-hydrolysed supplements scored
well in terms of acceptability in taste and cost; this makes
gelatin a potentially useful product since it provided similar
peak and total AA exposure than other collagen products.
Furthermore, our inability to measure the composition of
the protein sources actually used in this study until after
its conduct meant that we relied on previously collected
data, or that stated by the manufacturer which differed
to the final measured content (Table 1). The subsequent
discovery of the higher protein of this broth makes it
difficult to compare the bioavailability based on their actual
protein intake. However, since the serves used in this study
are the commonly consumed or recommended amounts of
these protein sources, it did allow real-life insight into the
AA profiles.
In summary, our study characterized the blood AA profiles
following the intake of a range of dairy and collagen supplements
providing 20 g of protein, and a common serve of beef broth
of higher total protein. While protein sources of similar origin
contained a comparable total AA profile, consumption of dairy
proteins provided a more pronounced amount of EAA and
leucine than collagen sources, with hydrolysed casein showing
increased bioavailability of AAs than an intact form. Intake
of collagen proteins achieved a greater peak concentration of
glycine, with small differences between hydrolysed and non-
hydrolysed forms. Although the total AA content of the bone
broth was greater, a lower and more sustained blood AA profile
seems likely. This information may help to inform protocols for
achieving ideal blood AA responses once the optimal support
for the synthesis of collagenous tissues is identified. However,
the cost and palatability of these dietary and supplement sources
should be considered.
DATA AVAILABILITY STATEMENT
All datasets generated for this study are included in the
manuscript/Supplementary Files.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by The Human Ethics Committee of the Australian
Institute of Sport. The patients/participants provided their
written informed consent to participate in this study.
AUTHOR CONTRIBUTIONS
RA, LB, and GS were involved in study design. RA and NT was
involved in data collection, data analysis, and statistical analysis
RA, LB, GS, and NT were involved in results interpretation,
drafting, reviewing, and revising the initial manuscript.
FUNDING
This study, funded by a grant administered by the Center
for Exercise and Nutrition, Mary Mackillop Institute
for Health Research, Australian Catholic University,
and provided by the ACT Brumbies Super Rugby
Team, was conducted at the Australian Institute of
Sport. Whilst the ACT Brumbies provided the funding
for the study; they had no direct role in any part of
the study.
ACKNOWLEDGMENTS
Amino acid analysis was facilitated using infrastructure
provided by the Australian Government through the National
Collaborative Research Infrastructure Strategy (NCRIS).
SUPPLEMENTARY MATERIAL




1. Couppe C, Kongsgaard M, Aagaard P, Vinther A, Boesen M, Kjaer M,
et al. Differences in tendon properties in elite badminton players with or
without patellar tendinopathy. Scand J Med Sci Sports. (2013) 23:e89–95.
doi: 10.1111/sms.12023
2. Kongsgaard M, Reitelseder S, Pedersen TG, Holm L, Aagaard P, Kjaer M, et al.
Region specific patellar tendon hypertrophy in humans following resistance
training. Acta Physiol. (2007) 191:111–21. doi: 10.1111/j.1748-1716.2007.
01714.x
3. Zhang ZJ, Ng GY, Fu SN. Effects of habitual loading on patellar tendon
mechanical and morphological properties in basketball and volleyball
players. Eur J Appl Physiol. (2015) 115:2263–9. doi: 10.1007/s00421-015-
3209-6
4. Galloway MT, Lalley AL, Shearn JT. The role of mechanical loading in tendon
development, maintenance, injury, and repair. J Bone Joint Surg Am. (2013)
95:1620–8. doi: 10.2106/JBJS.L.01004
5. Morton RW, McGlory C, Phillips SM. Nutritional interventions to augment
resistance training-induced skeletal muscle hypertrophy. Front Physiol. (2015)
6:245. doi: 10.3389/fphys.2015.00245
Frontiers in Nutrition | www.frontiersin.org 9 October 2019 | Volume 6 | Article 163
Alcock et al. Plasma Amino Acid Concentrations
6. Morton RW,Murphy KT, McKellar SR, Schoenfeld BJ, Henselmans M, Helms
E, et al. A systematic review, meta-analysis and meta-regression of the effect
of protein supplementation on resistance training-induced gains in muscle
mass and strength in healthy adults. Br J Sports Med. (2018) 52:376–84.
doi: 10.1136/bjsports-2017-097608
7. Phillips SM. Dietary protein for athletes: from requirements to metabolic
advantage. Appl Physiol Nutr Metab. (2006) 31:647–54. doi: 10.1139/h06-035
8. Phillips SM. A brief review of critical processes in exercise-induced
muscular hypertrophy. Sports Med. (2014) 44 (Suppl. 1):S71–7.
doi: 10.1007/s40279-014-0152-3
9. Phillips SM, Van Loon LJ. Dietary protein for athletes: from requirements
to optimum adaptation. J Sports Sci. (2011) 29 (Suppl. 1):S29–38.
doi: 10.1080/02640414.2011.619204
10. Baar K. Stress relaxation and targeted nutrition to treat patellar tendinopathy.
Int J Sport Nutr Exerc Metab. (2019) 29:453–7. doi: 10.1123/ijsnem.2018-0231
11. Curtis L. Nutritional research may be useful in treating tendon injuries.
Nutrition. (2016) 32:617–9. doi: 10.1016/j.nut.2015.12.039
12. Kjaer M, Jorgensen NR, Heinemeier K, Magnusson SP. Exercise and
regulation of bone and collagen tissue biology. ProgMol Biol Transl Sci. (2015)
135:259–91. doi: 10.1016/bs.pmbts.2015.07.008
13. Langberg H, Rosendal L, Kjaer M. Training-induced changes in peritendinous
type I collagen turnover determined by microdialysis in humans. J Physiol.
(2001) 534:297–302. doi: 10.1111/j.1469-7793.2001.00297.x
14. Dodd KM, Tee AR. Leucine and mTORC1: a complex
relationship. Am J Physiol Endocrinol Metab. (2012) 302:E1329–42.
doi: 10.1152/ajpendo.00525.2011
15. Barbosa AW, Benevides GP, Alferes LM, Salomao EM, Gomes-Marcondes
MC, Gomes L. A leucine-rich diet and exercise affect the biomechanical
characteristics of the digital flexor tendon in rats after nutritional recovery.
Amino Acids. (2012) 42:329–36. doi: 10.1007/s00726-010-0810-1
16. Farup J, Rahbek SK, Vendelbo MH, Matzon A, Hindhede J, Bejder A,
et al. Whey protein hydrolysate augments tendon and muscle hypertrophy
independent of resistance exercise contraction mode. Scand J Med Sci Sports.
(2014) 24:788–98. doi: 10.1111/sms.12083
17. Kjaer M, Langberg H, Heinemeier K, Bayer ML, Hansen M,
Holm L, et al. From mechanical loading to collagen synthesis,
structural changes and function in human tendon. Scand J
Med Sci Sports. (2009) 19:500–10. doi: 10.1111/j.1600-0838.2009.
00986.x
18. Li P, Wu G. Roles of dietary glycine, proline, and
hydroxyproline in collagen synthesis and animal growth.
Amino Acids. (2018) 50:29–38. doi: 10.1007/s00726-017-
2490-6
19. Dideriksen KJ, Reitelseder S, Petersen SG, Hjort M, Helmark IC,
Kjaer M, et al. Stimulation of muscle protein synthesis by whey and
caseinate ingestion after resistance exercise in elderly individuals. Scand
J Med Sci Sports. (2011) 21:e372–83. doi: 10.1111/j.1600-0838.2011.
01318.x
20. Paxton JZ, Grover LM, Baar K. Engineering an in vitro model of a
functional ligament from bone to bone. Tissue Eng Part A. (2010) 16:3515–25.
doi: 10.1089/ten.tea.2010.0039
21. ShawG, Lee-Barthel A, RossML,Wang B, Baar K. Vitamin C-enriched gelatin
supplementation before intermittent activity augments collagen synthesis.Am
J Clin Nutr. (2017) 105:136–43. doi: 10.3945/ajcn.116.138594
22. Daneault A, Prawitt J, Fabien Soule V, Coxam V, Wittrant Y.
Biological effect of hydrolyzed collagen on bone metabolism. Crit
Rev Food Sci Nutr. (2017) 57:1922–37. doi: 10.1080/10408398.2015.
1038377
23. Schunck M, Oesser S. Specific collagen peptides benefit the biosynthesis of
matrix molecules of tendons and ligaments. J Int Soc Sports Nutr. (2013) 10:
P23. doi: 10.1186/1550-2783-10-S1-P23
24. Oertzen-Hagemann V, Kirmse M, Eggers B, Pfeiffer K, Marcus K, de
Marees M, et al. Effects of 12 weeks of hypertrophy resistance exercise
training combined with collagen peptide supplementation on the skeletal
muscle proteome in recreationally active men. Nutrients. (2019) 11.
doi: 10.3390/nu11051072
25. Zdzieblik D, Oesser S, Baumstark MW, Gollhofer A, Konig D. Collagen
peptide supplementation in combination with resistance training improves
body composition and increases muscle strength in elderly sarcopenic
men: a randomised controlled trial. Br J Nutr. (2015) 114:1237–45.
doi: 10.1017/S0007114515002810
26. Clark KL, Sebastianelli W, Flechsenhar KR, Aukermann DF, Meza F,
Millard RL, et al. 24-Week study on the use of collagen hydrolysate
as a dietary supplement in athletes with activity-related joint pain.
Curr Med Res Opin. (2008) 24:1485–96. doi: 10.1185/030079908X
291967
27. Oesser S, Schulze CH, Zdzieblik D, König D. Efficacy of specific bioactive
collagen peptides in the treatment of joint pain. Osteoarthr Cartil. (2016)
24:S189. doi: 10.1016/j.joca.2016.01.370
28. Praet SFE, Purdam CR, Welvaert M, Vlahovich N, Lovell G, Burke LM,
et al. Oral supplementation of specific collagen peptides combined with
calf-strengthening exercises enhances function and reduces pain in achilles
tendinopathy patients. Nutrients. (2019) 11:E76. doi: 10.3390/nu11010076
29. Bello AE, Oesser S. Collagen hydrolysate for the treatment of
osteoarthritis and other joint disorders: a review of the literature.
Curr Med Res Opin. (2006) 22:2221–32. doi: 10.1185/030079906X
148373
30. Van Vijven JP, Luijsterburg PA, Verhagen AP, van Osch GJ, Kloppenburg
M, Bierma-Zeinstra SM. Symptomatic and chondroprotective
treatment with collagen derivatives in osteoarthritis: a systematic
review. Osteoarthr Cartil. (2012) 20:809–21. doi: 10.1016/j.joca.2012.
04.008
31. Aito-Inoue M, Lackeyram D, Fan MZ, Sato K, Mine Y. Transport of
a tripeptide, Gly-Pro-Hyp, across the porcine intestinal brush-border
membrane. J Pept Sci. (2007) 13:468–74. doi: 10.1002/psc.870
32. Skov K, Oxfeldt M, Thogersen R, Hansen M, Bertram HC. Enzymatic
hydrolysis of a collagen hydrolysate enhances postprandial absorption
rate-a randomized controlled trial. Nutrients. (2019) 11:E1064.
doi: 10.3390/nu11051064
33. Stijak L, Kadija M, Djulejic V, Aksic M, Petronijevic N, Markovic B, et al.
The influence of sex hormones on anterior cruciate ligament rupture:
female study. Knee Surg Sports Traumatol Arthrosc. (2015) 23:2742–9.
doi: 10.1007/s00167-014-3077-3
34. Burke LM, Winter JA, Cameron-Smith D, Enslen M, Farnfield M, Decombaz
J. Effect of intake of different dietary protein sources on plasma amino
acid profiles at rest and after exercise. Int J Sport Nutr Exerc Metab. (2012)
22:452–62. doi: 10.1123/ijsnem.22.6.452
35. van Loon LJC, Saris WHM. Plasma insulin responses after ingestion of
different amino acid or protein mixtures with carbohydrate. Am J. (2000)
72:96–105. doi: 10.1093/ajcn/72.1.96
36. Imaoka T, Suou T, Hirayama C. A simplified gelatin tolerance test to
evaluate gastric and pancreatic proteolytic activities. Res Commun Chem
Pathol Pharmacol. (1992) 78:97–108.
37. Iwai K, Hasegawa T, Taguchi Y, Morimatsu F, Sato K, Nakamura Y, et al.
Identification of food-derived collagen peptides in human blood after oral
ingestion of gelatin hydrolysates. J Agric Food Chem. (2005) 53:6531–6.
doi: 10.1021/jf050206p
38. Alcock RD, Shaw GC, Burke LM. Bone broth unlikely to provide reliable
concentrations of collagen precursors compared with supplemental sources
of collagen used in collagen research. Int J Sport Nutr Exerc Metab. (2018)
29:265–72 . doi: 10.1123/ijsnem.2018-0139
39. Baar K. Minimizing injury and maximizing return to play:
lessons from engineered ligaments. Sports Med. (2017) 47:5–11.
doi: 10.1007/s40279-017-0719-x
40. Likert R. A technique for the Measurement of Attitudes. (1932). New York, NY:
The Science Press. Available online at: http://worldcat.org /z-wcorg/ database
41. Yeh ST. Using trapezoidal rule for the area under a curve calculation. In:
Proceedings of the 27th Annual SAS R© User Group International. Cary, NC
(2002).
42. Scott A, Nordin C. Do dietary factors influence tendon metabolism? Adv Exp
Med Biol. (2016) 920:283–9. doi: 10.1007/978-3-319-33943-6_27
43. Lin HC, Zhao XT, Wang L. Fat absorption is not complete by midgut
but is dependent on load of fat. Am J Physiol. (1996) 271:G62–7.
doi: 10.1152/ajpgi.1996.271.1.G62
44. Boirie Y, Dangin M, Gachon P, Vasson MP, Maubois JL, Beaufrere B. Slow
and fast dietary proteins differently modulate postprandial protein accretion.
Frontiers in Nutrition | www.frontiersin.org 10 October 2019 | Volume 6 | Article 163
Alcock et al. Plasma Amino Acid Concentrations
Proc Natl Acad Sci USA. (1997) 94:14930–5. doi: 10.1073/pnas.94.26.
14930
45. Babraj JA, Cuthbertson DJ, Smith K, Langberg H, Miller B, Krogsgaard
MR, et al. Collagen synthesis in human musculoskeletal tissues
and skin. Am J Physiol Endocrinol Metab. (2005) 289:E864–9.
doi: 10.1152/ajpendo.00243.2005
46. Langberg H, Skovgaard D, Asp S, Kjaer M. Time pattern of exercise-induced
changes in type I collagen turnover after prolonged endurance exercise in
humans. Calcif Tissue Int. (2000) 67:41–4. doi: 10.1007/s00223001094
47. West DW, Lee-Barthel A, McIntyre T, Shamim B, Lee CA, Baar K.
The exercise-induced biochemical milieu enhances collagen content and
tensile strength of engineered ligaments. J. Physiol. (2015) 593:4665–75.
doi: 10.1113/JP270737
48. Langberg H, Skovgaard D, Petersen LJ, Bulow J, Kjaer M. Type I
collagen synthesis and degradation in peritendinous tissue after exercise
determined by microdialysis in humans. J Physiol. (1999) 521:299–306.
doi: 10.1111/j.1469-7793.1999.00299.x
49. Langberg H, Bülow J, Kjær M. Standardized intermittent static exercise
increases peritendinous blood flow in human leg. Clin Physiol. (1999) 19:89–
93. doi: 10.1046/j.1365-2281.1999.00148.x
50. Koopman R, Crombach N, Gijsen AP, Walrand S, Fauquant J, Kies AK, et al.
Ingestion of a protein hydrolysate is accompanied by an accelerated in vivo
digestion and absorption rate when compared with its intact protein. Am J
Clin Nutr. (2009) 90:106–15. doi: 10.3945/ajcn.2009.27474
51. Dallas DC, Sanctuary MR, Qu Y, Khajavi SH, Van Zandt AE,
Dyandra M, et al. Personalizing protein nourishment. Crit Rev
Food Sci Nutr. (2017) 57:3313–31. doi: 10.1080/10408398.2015.11
17412
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2019 Alcock, Shaw, Tee and Burke. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Nutrition | www.frontiersin.org 11 October 2019 | Volume 6 | Article 163
